Literature DB >> 2397869

[Blue rubber bleb nevus syndrome. 3 cases treated with a Nd:YAG laser and bipolar electrocoagulation].

V Maunoury1, D Turck, J M Brunetaud, R Marti, A Cortot, J P Farriaux, J C Paris.   

Abstract

This report concerns three patients with "blue rubber bleb nevus syndrome" presenting with recurrent digestive tract hemorrhage. Tuberous angiomas of the digestive tract associated with typical skin lesions as described by Bean led to diagnosis. Endoscopic coagulation with Nd:YAG laser and bipolar electrocoagulation "Bicap" of gastric and colonic angiomas was performed successfully without complication but did not avoid hemorrhagic recurrence originating from lesions located in the small bowel, as demonstrated during laparotomy in one case.

Entities:  

Mesh:

Year:  1990        PMID: 2397869

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  6 in total

1.  Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding.

Authors:  Steven J Fishman; C Jason Smithers; Judah Folkman; Dennis P Lund; Patricia E Burrows; John B Mulliken; Victor L Fox
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

2.  Blue Rubber Bleb Nevus Syndrome.

Authors:  John M. Andersen
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

3.  Hemangiomas of the pelvis.

Authors:  Marcus C B Tan; Matthew G Mutch
Journal:  Clin Colon Rectal Surg       Date:  2006-05

4.  Diagnosis and treatment of blue rubber bleb nevus syndrome in children.

Authors:  Zhao-Hui Deng; Chun-Di Xu; Shun-Nian Chen
Journal:  World J Pediatr       Date:  2008-02       Impact factor: 2.764

5.  Blue rubber bleb nevus: a rare cause of GI bleeding-review of management.

Authors:  Mamoon Ur Rashid; Muzammil Muhammad Khan; Waqas Ullah; Ishtiaq Hussain; Abu Hurairah
Journal:  BMJ Case Rep       Date:  2019-12-16

6.  Endoscopic management of blue rubber bleb nevus syndrome: A case report.

Authors:  Weiwei Guo; Zhaoyuan Peng; Xiaowei Tang; Zhifei Zhao; Zheng Liu
Journal:  Exp Ther Med       Date:  2013-09-17       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.